• DNDi logo
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Global Headquarters
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia/India
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi logo
  • DNDi logo
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Global Headquarters
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia/India
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Close-up on Paediatric HIV

Home > News

Close-up on Paediatric HIV

Gloria and Simon go for regular check-ups at the health centre to make sure that Simon is healthy and the dosage of his treatment is adapted as he grows. Gloria refills Simon’s medicines every month because the syrup cannot be kept at room temperature for more than six weeks. She gets them for free at the health center, which means that for a full day each month, she is away from her job and her other children.
30 Apr 2015
Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

An estimated 3.3 million children under 15 years of age were living with HIV worldwide in 2012. During that one year alone, some 260,000 children were infected with HIV (over 90% of these were in sub-Saharan Africa). A further 210,000 died of the disease, the vast majority before reaching the age of two and without having been diagnosed. Most of these deaths could have been avoided had diagnosis been carried out in the first weeks of infection and treatment immediately commenced.  While the absolute number of infants newly infected with HIV is now declining due to international efforts made in prevention of mother to child transmission, the need for paediatric treatment will continue to increase at least until 2020.

Gloria is an HIV-positive single mother of three children, two of whom are not HIV positive. As she lost her regular job when she was diagnosed with HIV, she now sells cooked sweet potatoes in the mornings before her children wake, and does people's laundry to support her family. Simon, her son, 21 months old, is HIV positive. [Gloria and Simon’s names have been changed and are not their real names.]
Gloria is an HIV-positive single mother of three children, two of whom are not HIV positive. As she lost her regular job when she was diagnosed with HIV, she now sells cooked sweet potatoes in the mornings before her children wake, and does people’s laundry to support her family. Simon, her son, 21 months old, is HIV positive. [Gloria and Simon’s names have been changed and are not their real names.]
Gloria and Simon live in the outskirts of Nairobi, Kenya. It is estimated that some 190’000 children are living with HIV in Kenya.
Gloria and Simon live in the outskirts of Nairobi, Kenya. It is estimated that some 190’000 children are living with HIV in Kenya.
Only few antiretroviral drugs are available for HIV-positive children. The current treatments combine three or four drugs which act together to suppress HIV replication. The recommended drugs for young children are comprised of a syrup that requires refrigeration, is cumbersome to carry, complicated to dose, and tastes awful; combined with a dispersible tablet.
Only few antiretroviral drugs are available for HIV-positive children. The current treatments combine three or four drugs which act together to suppress HIV replication. The recommended drugs for young children are comprised of a syrup that requires refrigeration, is cumbersome to carry, complicated to dose, and tastes awful; combined with a dispersible tablet.
As Gloria cannot afford a refrigerator and has no electricity at home, she stores Simon’s medicines in a pail containing water and sand in order to keep it cool.
As Gloria cannot afford a refrigerator and has no electricity at home, she stores Simon’s medicines in a pail containing water and sand in order to keep it cool.
The routine of Gloria giving medicine to Simon twice a day involves her first, to syringe out the correct amount of syrup. She complains of the syrup ‘clotting’, making it hard to get into the syringe.
The routine of Gloria giving medicine to Simon twice a day involves her first, to syringe out the correct amount of syrup. She complains of the syrup ‘clotting’, making it hard to get into the syringe.
Gloria struggles every day to administer the syrup to Simon as he sometimes cries and tries to get away because of the bad taste he can hardly stand.
Gloria struggles every day to administer the syrup to Simon as he sometimes cries and tries to get away because of the bad taste he can hardly stand.
The other two medicines for Simon come in a dispersible tablet that Gloria disperses in a small cup containing clean water. This can be also a challenge for certain households where there is no clean water readily available.
The other two medicines for Simon come in a dispersible tablet that Gloria disperses in a small cup containing clean water. This can be also a challenge for certain households where there is no clean water readily available.
Gloria administers to Simon his other two medicines. He often refuses it because he is still remembers the taste of the syrup from just before.
Gloria administers to Simon his other two medicines. He often refuses it because he is still remembers the taste of the syrup from just before.
Gloria is relieved every time the battle of giving the medicine to Simon is over, but she will have to repeat the same process in several hours. She says that it gets harder, not easier, as Simon gets older. While, technically, kids are meant to switch to pills when they grow bigger, many of them cannot swallow pills even when they are ‘technically’ old enough to do so.
Gloria is relieved every time the battle of giving the medicine to Simon is over, but she will have to repeat the same process in several hours. She says that it gets harder, not easier, as Simon gets older. While, technically, kids are meant to switch to pills when they grow bigger, many of them cannot swallow pills even when they are ‘technically’ old enough to do so.
Simon is tended to by the FACES Programme (Family AIDS Care and Education Services) in Nairobi.
Simon is tended to by the FACES Programme (Family AIDS Care and Education Services) in Nairobi.
Gloria and Simon go for regular check-ups at the health centre to make sure that Simon is healthy and the dosage of his treatment is adapted as he grows. Gloria refills Simon’s medicines every month because the syrup cannot be kept at room temperature for more than six weeks. She gets them for free at the health center, which means that for a full day each month, she is away from her job and her other children.
For Gloria and Simon, and all families with HIV positive children, there is an urgent need to make treatments available for children, which are safer, easier to carry and store, easier to give and to take, and which will ensure their greatest chance to reach adulthood. As Gloria says, she finds the courage every day to give the medicine to Simon no matter what, because she knows that one day ‘he will be a great man’.
For Gloria and Simon, and all families with HIV positive children, there is an urgent need to make treatments available for children, which are safer, easier to carry and store, easier to give and to take, and which will ensure their greatest chance to reach adulthood. As Gloria says, she finds the courage every day to give the medicine to Simon no matter what, because she knows that one day ‘he will be a great man’.
Children Paediatric HIV Africa Kenya

Read, watch, share

Loading...
Lab activities
Press releases
29 Jun 2022

DNDi welcomes new PAHO recommendations for the treatment of leishmaniasis in the Americas

Publications
16 Jun 2022

DNDi‘s Commitment to the Kigali Declaration

Caregiver prepares 4-in-1 HIV treatment for child
Press releases
14 Jun 2022

Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in South Africa

Nurse with HIV-VL patient
Publications
8 Jun 2022

The Science Explained: Evaluating new treatment regimens for visceral leishmaniasis in people living with HIV in India and Ethiopia

Doctor with a patient
Press releases
8 Jun 2022

New WHO treatment guidelines offer hope for people co-infected with visceral leishmaniasis and HIV

Doctor talking with patient during a consultation
Press releases
1 Jun 2022

Thai partners unite with DNDi to improve access to treatments and diagnostics for people with hepatitis C in Thailand

Statements
24 May 2022

DNDi interventions at the 75th World Health Assembly

Hand holding pill
Publications
23 May 2022

DNDi briefing document: Best science for all

VIEW ALL

Help neglected patients

To date, we have delivered twelve new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
DNDi logo
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By clicking 'Accept All', you are agreeing to our use of cookies. Click on 'Customize' to accept only some cookies.
Customize
ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesNo description
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
_hjSessionUser_11288441 yearNo description
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo